BPG is committed to discovery and dissemination of knowledge
Prospective Study
Copyright: ©Author(s) 2026.
World J Orthop. Mar 18, 2026; 17(3): 114005
Published online Mar 18, 2026. doi: 10.5312/wjo.v17.i3.114005
Table 1 Indications and contraindications for isolated meniscal allograft transplantation
BMI < 35 kg/m2
Normal coronal and sagittal alignment of the knee
Normal ligamentous stability
No articular cartilage lesions in the compartment with corresponding pathologic meniscus
Patient willing and able to comply with all postoperative restrictions and rehabilitation protocols
Patient with realistic post-surgical expectations
Table 2 Post-operative rehabilitation protocol for isolated meniscal allograft transplantation
Post-operative rehabilitation protocol
Begin physical therapy 3-5 days after surgery
Touch down weight bearing to 25% partial weight bearing is allowed for 6 weeks. Full weight bearing at 6 weeks. Upon initiation of full weight bearing an unloader brace is used to off-load the surgical compartment
While ambulating, the knee is locked in extension with a brace for 6 weeks
Range of motion from 0-45 degrees until 2 weeks post-operatively
Range of motion from 0-60 degrees from post-operative weeks 2-4
Range of motion from 0-90 degrees from post-operative weeks 4-6
Advance to range of motion as tolerated after post-operative week 6, avoiding forced flexion for 3-4 months
Return to work for a sedentary job can be as early as one week post-operatively. For strenuous work, it will take approximately 3-4 months
Low-impact exercises are allowed at 8 weeks with running after 6 months. Light to moderate sport is allowed at 6 months to 9 months with strenuous sport not recommended. Each case is unique and modifying return to work and sport to a certain degree is necessary for every patient
Table 3 Individual patient characteristics
Patient
Age (years)
Sex
Laterality
Need for follow up procedure
121FemaleLateralNo
235FemaleLateralNo
356MaleMedialNo
414MaleLateralNo
514MaleLateralNo
617MaleLateralNo
717FemaleLateralNo
823FemaleLateralNo
919MaleLateralNo
1025FemaleLateralYes (meniscal re-tear)
1119FemaleMedialYes (arthrofibrosis)
1220FemaleLateralNo
1317MaleLateralNo
1419MaleLateralNo
1517FemaleLateralNo
Table 4 Patient demographic summation
Patients (n)
15
Average age (years)22.2 ± 10.7 (14-56)
SexFemale 53% (8/15), male 47% (7/15)
LateralityLateral 87% (13/15), medial 13% (2/15)
Revision rate13% (2/15)
Avg follow up57 months (24-111)
Table 5 Patient reported outcomes and pain scores

Preop (n = 15)
6 months (n = 15)
P value
1 year (n = 15)
P value
2+ years (average = 4.7 years) (n = 15)
P value
Pain frequency6.9 ± 2.53.2 ± 2.5P < 0.0013.1 ± 2.2P < 0.0013.4 ± 3.6P = 0.001
Pain severity6.2 ± 2.63.4 ± 2.5P = 0.0023.3 ± 2.9P < 0.0012.9 ± 2.5P < 0.001
IKDC function37.1 ± 15.759.4 ± 17.2P = 0.00170.1 ± 22.1P < 0.00174.2 ± 17.7P < 0.001
Lysholm52.2 ± 20.672.5 ± 17.9P = 0.00180.1 ± 15.4P < 0.00183.1 ± 17.7P < 0.001
KOOS pain score53.9 ± 14.280.4 ± 15.3P < 0.00184.4 ± 15.6P < 0.00186.1 ± 15.0P < 0.001
KOOS symptom45.7 ± 16.568.6 ± 16.8P = 0.00482.6 ± 17.8P < 0.00182.4 ± 16.3P < 0.001
KOOS ADL65.5 ± 18.988.4 ± 13.3P < 0.00190.7 ± 13.6P < 0.00189.4 ± 12.2P < 0.001
KOOS sport26.3 ± 25.552.1 ± 28.0P = 0.02166.0 ± 30.0P < 0.00169.7 ± 27.7P < 0.001
KOOS QoL30.8 ± 23.953.3 ± 18.4P = 0.01462.1 ± 30.7P = 0.00266.0 ± 29.0P = 0.001
PSF12 score36.9 ± 9.143.5 ± 9.4P = 0.03648.2 ± 9.2P = 0.00349.5 ± 7.7P < 0.001
MSF12 score45.7 ± 12.154.5 ± 10.3P = 0.00855.7 ± 9.3P = 0.00156.3 ± 7.7P = 0.002